Aluminum foil reflector for newborn jaundice treatment
Part of Genetic & congenital clinical trials.
This trial tests whether placing a simple aluminum foil reflector under the lights during phototherapy can help clear jaundice faster in newborns. It aims to make treatment more effective without extra devices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Newborn with jaundice severe enough to need light therapy
- Born at 37 weeks or later, and less than 14 days old
- No known blood cell breakdown conditions like G6PD deficiency
- Bilirubin levels not dangerously close to needing a blood exchange
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new phototherapy (special light treatment) device to treat newborn jaundice. It may help by seeing whether this device can treat jaundice safely and effectively.
This trial tests if giving a zinc or bile acid medicine alongside light therapy helps break down jaundice faster in newborns. It could shorten treatment time for babies who need phototherapy in their first week of life.
This trial tests different ways to give light therapy to newborns with jaundice. It compares different approaches to see which is best, and may help parents understand the most effective treatment for their baby.
This study tests whether gentle foot reflexology and massage can help newborns with jaundice (high bilirubin levels in the blood) recover faster during light therapy treatment. Jaundice is common in newborns and is usually treated with special lights; this trial explores whether touch therapy might improve outcomes.
This trial tests whether giving probiotics (healthy bacteria) to newborns with jaundice helps them get better faster when they are also receiving light therapy (phototherapy). It is for babies with moderate jaundice who need treatment and do not have other serious health issues.
This trial compares two medicines, fenofibrate and phenobarbitone, added to standard light therapy to see which works better at lowering bilirubin levels in full-term newborns with jaundice. It aims to find a faster or more effective way to treat jaundice and reduce the need for more intensive treatments.
Hear when a new Newborn Jaundice trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.